Company Search:
Advanced Search
Sponsored Links
Insys Therapeutics Incorporated Company Snapshot
Insys Therapeutics Incorporated operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Insys Therapeutics Incorporated with three other companies in this sector in the United States: Five Prime Therapeutics Inc (2015 sales of $379.80 million ), Albany Molecular Research Incorporated ($402.36 million of which 54% was API), and Medpace Holdings Inc ($320.10 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Insys Therapeutics Incorporated
  Stock Performance Chart for Insys Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 9.97
(Figures in U.S. Dollars)
1 Week -10.2%   13 Weeks -10.2%  
4 Weeks 9.7%   52 Weeks -44.6%  
Insys Therapeutics Incorporated Key Data:
  Ticker: INSY Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 330,797,000
(Year Ending Jan 2016).
Employees: 510
  Currency: U.S. Dollars Market Cap: 715,548,575
  Fiscal Yr Ends: December Shares Outstanding: 71,770,168
  Share Type: Common Closely Held Shares: 48,781,612
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.